期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

核苷（酸）类似物抗乙型肝炎病毒耐药机制及临床策略 被引量：5

下载PDF
导出
摘要 我国是乙型肝炎病毒（hepatitis B virus，HBV）高流行地区，人群感染率达到10％，由HBV持续感染引起的慢性乙型肝炎、肝硬化、原发性肝癌严重威胁着我国人民的健康。
作者 付丽娟 滕旭 谷鸿喜
机构地区 黑龙江省医院感染内科 哈尔滨医科大学微生物教研室
出处 《中国医药》 2013年第10期1513-1514,共2页 China Medicine
基金 国家自然科学基金资助项目（31100077）
关键词 核苷(酸)类似物 乙型肝炎病毒 耐药机制 临床策略
分类号 R512.62 [医药卫生—内科学]
  • 相关文献

参考文献24

  • 1Lau DT, Khokhar MF, Doo E, et al. Long-term therapy of chronichepatitis B with lamivudine. Hepatology,2000,32(4 Pt 1 ) :828-834.
  • 2Hoofnagle JH,Doo E,Liang TJ, et al. Management of hepatitis B:summary of a clinical research workshop. Hepatology, 2007 , 45(4). :1056-1075.
  • 3Nassal M. Hepatitis B viruses: reverse transcription a differentway. Virus Res, 2008,134(1-2) :235-249.
  • 4Girones R, Miller RH. Mutation rate of the hepadnavirus genome.Virology, 1989,170(2):595-597.
  • 5Yurdaydin C, Idilman R, Bozkaya H, et al. Natural history andtreatment of chronic delta hepatitis. J Viral Hepat, 2010,17(11):749-756.
  • 6Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association..慢性乙型肝炎防治指南(2010年版)[J].胃肠病学,2011,16(6):351-366. 被引量：111
  • 7邓俊,张欣欣.核苷(酸)类药物耐药机制及其对策[J].中国实用内科杂志,2007,27(17):1402-1404. 被引量：8
  • 8Thomas H, Foster G, Platis D. Mechanisms of action of interferonand nucleoside analogues. J Hepatol, 2003,39 Suppl 1 :S93-98.
  • 9Damerow H, Yuen L, Wiegand J, et al. Mutation pattern of lami-vudine resistance in relation to hepatitis B genotypes : hepatitis Bgenotypes differ in theirlamivudine resistance associated mutationpattern. J Med Virol, 2010,82( 11) :1850-1858.
  • 10Bartholomeusz A,Locamini SA. Antiviral drug resistance : clinicalconsequences and molecular aspects. Semin Liver Dis, 2006 , 26(2) :162-170.

二级参考文献21

共引文献117

同被引文献60

  • 1Shenzhen Eastlake Hospital, Shenzhen 518020, China (Chen JY) ,and National Key Laboratory of Virology (Wuhan University) ,Department of Infectious Diseases, Renmin Hospital, Wuhan University, Wuhan 430060, China(Wang LW, Sun XM and Gong ZJ).Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):393-397. 被引量：8
  • 2任仲轩,裴琇,王麟士,刘金星,曹治宸.慢性活动性肝炎多重感染[J].中华传染病杂志,1994,12(3):170-171. 被引量：25
  • 3Ganem D,Prince AM. Hepatitis B virus infection—natural historyand clinical consequences [ J]. N Engl J Med, 2004, 350 ( 11):1118-1129.
  • 4Chen Z,Zeng Y,Wen TF,et al. Dual grafts live donor livertransplantation for acute-on-chronic hepatitis B liver failure [J].Transplant Proc,2010,42( 10) :4552-4554.
  • 5Katoonizadeh A, Laleman W, Verslype C, et al. Early features ofacute-on-chronic alcoholic liver failure: a prospective cohort study[J]. Gut,2010,59(11) :1561-1569.
  • 6Srivastava R, Aggarwal R, Sachdeva S, et al. Adaptive immuneresponses during acute uncomplicated and fulminant hepatitis E[J]. J Gastroenterol Hepatol,2011,26(2) :306-311.
  • 7Bhatia V, Singhal A, Panda SK, et al, A 20-year single-centerexperience with acute liver failure during pregnancy : is theprognosis really worse [ J]. Hepatology,2008,48(5 ) : 1577-1585.
  • 8Jalan R, Williams R. Acute-on-cKronic liver failure: pathophysi-ological basis of therapeutic options [J]. Blood Purif, 2002, 20(3):252-261.
  • 9Sokal E M, Paganelli M, Wirth S, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: Consensus of an expert panel on be- half of the European Society of Pediatric Gastroenterolo- gy, Hepatology and Nutrition [ J ]. J Hepatol, 2013,59 (4) :814-829.
  • 10Herbers U, Amini-Bavil-Olyaee S, Mueller A, et al. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains[J].J Viral Hepat, 2013,20(2) :141-148.

引证文献5

二级引证文献22

中国医药
2013年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部